<root>
	<PMID Version="1">24788655</PMID>
	<Summary>
		1: Ouyang M, Li Y, Ye S, Ma J, Lu L, Lv W, Chang G, Li X, Li Q, Wang S, Wang W.MicroRNA profiling implies new markers of chemoresistance of triple-negativebreast cancer. PLoS One. 2014 May 2;9(5):e96228. doi:10.1371/journal.pone.0096228. eCollection 2014. PubMed PMID: 24788655; PubMedCentral PMCID: PMC4008525.
	</Summary>
	<MeshHeadingList>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D000903">Antibiotics, Antineoplastic</DescriptorName>
			<QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D002460">Cell Line</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D045744">Cell Line, Tumor</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D002470">Cell Survival</DescriptorName>
			<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
			<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D016000">Cluster Analysis</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D003131">Combined Modality Therapy</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D004317">Doxorubicin</DescriptorName>
			<QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D019008">Drug Resistance, Neoplasm</DescriptorName>
			<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="Y" UI="D020869">Gene Expression Profiling</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="Y" UI="D015972">Gene Expression Regulation, Neoplastic</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D035683">MicroRNAs</DescriptorName>
			<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D020411">Oligonucleotide Array Sequence Analysis</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D020133">Reverse Transcriptase Polymerase Chain Reaction</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D064726">Triple Negative Breast Neoplasms</DescriptorName>
			<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
			<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
			<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D014408">Tumor Markers, Biological</DescriptorName>
			<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D015854">Up-Regulation</DescriptorName>
			<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
	    </MeshHeading>
	</MeshHeadingList>
</root>
